Table 2.

RV volumes and EFs by single-beat full-volume 3DE versus CMRI

Group	Measurement	3DE	CMRI	P∗
PH	EDV (mL)	158 ± 53	154 ± 52	.043
	ESV (mL)	100 ± 44	92 ± 47	<.0001
	SV (mL)	58 ± 18	63 ± 17	.011
	EF (%)	39 ± 11	43 ± 14	.00029
Carcinoid heart disease	EDV (mL)	182 ± 69	185 ± 71	.21
	ESV (mL)	67 ± 28	62 ± 3	.01
	SV (mL)	115 ± 42	124 ± 45	.014
	EF (%)	64 ± 5	68 ± 7	.001
Healthy volunteers	EDV (mL)	105 ± 26	117 ± 27	<.0001
	ESV (mL)	41 ± 12	41 ± 14	.80
	SV (mL)	65 ± 16	76 ± 18	<.0001
	EF (%)	61 ± 5	65 ± 7	.014
Carcinoid (no valvulopathy)	EDV (mL)	88 ± 21	98 ± 27	.05
	ESV (mL)	32 ± 13	30 ± 14	.24
	SV (mL)	56 ± 10	68 ± 14	.009
	EF (%)	64 ± 7	71 ± 7	.004

ESV, End-systolic volume.

Data are expressed as mean ± SD.

^∗Paired Student t tests.